These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21925413)

  • 1. It's not about the money.
    Rosen CD
    Spine J; 2011 Aug; 11(8):700-2. PubMed ID: 21925413
    [No Abstract]   [Full Text] [Related]  

  • 2. Public Disclosure of Payments to Physicians From Industry.
    Ornstein C
    JAMA; 2017 May; 317(17):1749-1750. PubMed ID: 28464158
    [No Abstract]   [Full Text] [Related]  

  • 3. Industry support and professional medical associations.
    Jackson RH
    JAMA; 2009 Aug; 302(7):738; author reply 739. PubMed ID: 19690304
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry support and professional medical associations.
    Smith CD; Buyske J; Talamini MA
    JAMA; 2009 Aug; 302(7):738-9; author reply 739. PubMed ID: 19690303
    [No Abstract]   [Full Text] [Related]  

  • 5. Too friendly? Teaching hospitals revisit ties to pharmaceutical firms.
    Romano M
    Mod Healthc; 2003 Jul; 33(28):17. PubMed ID: 12884711
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial policies on financial disclosure.
    Jacobson MF; Sharpe VA; Angell M; Ashford NA; Blum A; Chary LK; Cho M; Coull BC; Davis D; Doolittle RF; Egilman D; Epstein SS; Greenberg M; Hooper K; Huff J; Joshi TK; Krimsky S; LaDou J; Levenstein C; Miles S; Needleman H; Pellegrino ED; Ravanesi B; Sass J; Schecter A; Schneiderman JS; Schubert D; Soffritti M; Suzuki D; Takaro TK; Temple NJ; Terracini B; Thompson A; Wallinga D; Wing S
    Nat Neurosci; 2003 Oct; 6(10):1001. PubMed ID: 14513030
    [No Abstract]   [Full Text] [Related]  

  • 7. Financial disclosure for review authors.
    Nat Neurosci; 2003 Oct; 6(10):997. PubMed ID: 14513027
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial policies on financial disclosure.
    Carroll BJ; Rubin RT
    Nat Neurosci; 2003 Oct; 6(10):999-1000; author reply 1000-1. PubMed ID: 14513028
    [No Abstract]   [Full Text] [Related]  

  • 9. Unreported financial disclosures.
    Rosenberg RN
    Arch Neurol; 2008 Jul; 65(7):992. PubMed ID: 18625879
    [No Abstract]   [Full Text] [Related]  

  • 10. Research funding, conflicts of interest, and the meta-methodology of public relations.
    Rampton S; Stauber J
    Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
    [No Abstract]   [Full Text] [Related]  

  • 11. Taking money from the drug industry: the rules tighten.
    Elliott C
    Hastings Cent Rep; 2003; 33(4):6-7. PubMed ID: 12971053
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conflict of interest in clinical research--trends in guidelines for research ethics in Japan and other countries].
    Tashiro M
    Seishin Shinkeigaku Zasshi; 2010; 112(11):1130-5. PubMed ID: 21351693
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulating spoons.
    Bush A
    Eur Respir J; 2008 Apr; 31(4):699-700. PubMed ID: 18378781
    [No Abstract]   [Full Text] [Related]  

  • 14. Financial ties to industry cloud major depression study; at issue: whether it's safe for pregnant women to stay on medication; JAMA asks author to explain.
    Armstrong D
    Wall St J (East Ed); 2006 Jul; ():A1, A9. PubMed ID: 16909497
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 16. Disclosure UK website gives "illusion of transparency," says Goldacre.
    Kmietowicz Z
    BMJ; 2016 Jul; 354():i3760. PubMed ID: 27384062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disclosure of conflicts of interest in the Tijdschrift voor Psychiatrie].
    Bergoets M; Pieters G
    Tijdschr Psychiatr; 2009; 51(12):893-7. PubMed ID: 20047169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicts of interest, institutional corruption, and pharma: an agenda for reform.
    Rodwin MA
    J Law Med Ethics; 2012; 40(3):511-22. PubMed ID: 23061578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public disclosure of conflicts of interest: moving the policy debate forward.
    Campbell EG
    Arch Intern Med; 2010 Apr; 170(8):667. PubMed ID: 20421548
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted therapies: Manufacturer sponsorship bias in economic analyses matters.
    Kerr D; Elzawawy A
    Nat Rev Clin Oncol; 2012 May; 9(6):309-10. PubMed ID: 22547216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.